These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11202216)

  • 1. Treatment of type 2 diabetes mellitus in children and adolescents.
    Silverstein JH; Rosenbloom AL
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1403-9. PubMed ID: 11202216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focus on insulin resistance in type 2 diabetes: therapeutic implications.
    Reusch JE
    Diabetes Educ; 1998; 24(2):188-93. PubMed ID: 9555358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of the glycemic control and therapeutic regimen for diabetes mellitus in the Japanese patients on hemodialysis.
    Sanai T; Tada H; Ono T; Fukumitsu T
    Diabetes Metab Syndr; 2015; 9(4):244-6. PubMed ID: 25866098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hyperglycemia in minority children with type 2 diabetes mellitus.
    Castells S
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():531-40. PubMed ID: 12017228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges Related to Glycemic Control in Type 2 Diabetes Mellitus Patients.
    Kheirandish M; Mahboobi H; Yazdanparast M; Kamal MA
    Curr Drug Metab; 2017; 18(2):157-162. PubMed ID: 28093996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses to acute exercise in type 2 diabetes, with an emphasis on metabolism and interaction with oral hypoglycemic agents and food intake.
    Galbo H; Tobin L; van Loon LJ
    Appl Physiol Nutr Metab; 2007 Jun; 32(3):567-75. PubMed ID: 17510698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of blood glucose in type 2 diabetes mellitus.
    Ripsin CM; Kang H; Urban RJ
    Am Fam Physician; 2009 Jan; 79(1):29-36. PubMed ID: 19145963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating dual defects in diabetes: insulin resistance and insulin secretion.
    Bohannon NJ
    Am J Health Syst Pharm; 2002 Dec; 59 Suppl 9():S9-13. PubMed ID: 12489381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary failure to oral hypoglycaemic agents in non-obese patients with non-insulin-dependent diabetes is related to reduced insulin release.
    Pontiroli AE; Calderara A; Maffi P; Bonisolli L; Carenini A; Piatti PM; Monti LD; Gallus G; Pozza G; Illeni MT
    Diabete Metab; 1989; 15(2):79-84. PubMed ID: 2661281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers.
    Raptis SA; Dimitriadis GD
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S265-87. PubMed ID: 11460577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
    Gastaldelli A; Nauck MA; Balena R
    Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for type 2 diabetes mellitus.
    Elson DF; Meredith M
    WMJ; 1998 Mar; 97(3):49-54. PubMed ID: 9540451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Etiology of and therapy for type-2 diabetes mellitus].
    Kazuga M
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):527-31. PubMed ID: 15052815
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapies for newly-onset diabetic patients].
    Kawamori R
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():525-32. PubMed ID: 15779435
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug interactions of clinical importance with antihyperglycaemic agents: an update.
    Scheen AJ
    Drug Saf; 2005; 28(7):601-31. PubMed ID: 15963007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.